They revealed that the proliferation ability and cell competition were reduced in fms-like receptor tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive human AML cells upon inhibition of the enzymatic activity of NOX4 and p22phox. The gene discussed is NOX4; the disease is acute myeloid leukemia.